Table 4.
Outcome | Domain | Subdomain | Evaluation Tools | Study | ||
---|---|---|---|---|---|---|
Measures | per-Based | pr-Based | ||||
Medical Benefit | Functional capacity | Physical activity monitoring |
Steps per day | x | [19,38,44] | |
Physical activity level | x | [32] | ||||
PAEE | x | [32] | ||||
METS | x | [24,34,44] | ||||
IPAQ | x | [42,44] | ||||
DASI | x | [26] | ||||
Exercise capacity | VO2 | x | [7,19,20,22,30,32,33,37,40,41,42] | |||
Aerobic threshold/6MWT | x | [27,28,32,39,43] | ||||
Peak load | x | [7,19,22,32,33,41,42] | ||||
Respiratory response to exercise | VT | x | [19,20] | |||
RER | x | [19,20,22,32,33,41,42] | ||||
Borg scale | x | [19,20,24,41,42] | ||||
Heart rate response to exercise | Peak heart rate | x | [19,20,21,22,24,27,30,32,33,34,40,41,42,43] | |||
Systolic function | LVEF | x | [35,40] | |||
Risk factors control | Blood values |
Total cholesterol | x | [20,24,25,26,27,37,40,41,42] | ||
HDL-cholesterol | x | [20,24,25,27,37,40,41] | ||||
LDL-cholesterol | x | [20,24,25,27,37,40,41,42] | ||||
Triglycerides | x | [20,24,27,37] | ||||
Glucose | x | [20,24,26,37,40] | ||||
HOMA index | x | [20] | ||||
HbA1c | x | [24,41] | ||||
Blood pressure | SBP | x | [19,20,24,25,26,27,28,31,34,37,40,41,42,44] | |||
DBP | x | [19,20,24,25,26,28,31,34,37,40,41,42,44] | ||||
Body composition | Weight | x | [19,20,37,42] | |||
Body Mass Index | x | [19,20,22,24,25,32,37,41,42,44] | ||||
Waist-hip ratio | x | [24,25,27] | ||||
Waist circumference | x | [19,20,22,26,37,42,44] | ||||
Hip circumference | x | [19,20,37] | ||||
Participation | Quality of life | SF-36 | x | [7,19,22,24,26,28,41] | ||
SF-12 | x | [27,32] | ||||
WHOQOL | x | [31] | ||||
27-item MacNew | x | [33,38,44,45] | ||||
EQ-5D | x | [37,40] | ||||
Mood | HADS | x | [25,32,40,42] | |||
CDS | x | [28] | ||||
PHQ-9 | x | [32,41,42] | ||||
PSSS | x | [39] | ||||
MPSS | x | [42] | ||||
DASS-21 | x | [44,45] | ||||
Mortality | Number of deaths | [21,22,24,29,30,32,38,41,42] | ||||
Patient-Relevant Structural and Procedure Effects | Participation rate | [7,21,24,26,33,38,40,45] | ||||
Adherence | % who carried out the training | [7,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45] | ||||
Safety | Adverse events | [7,19,21,22,24,25,26,29,30,32,33,36,37,38,39,40,41,42,43] | ||||
Self-efficacy | Client satisfaction questionnaire | x | [27,32,33] | |||
Partner in health | x | [31] | ||||
Overall Illness Threat | x | [25] | ||||
Overall Self-efficacy | x | [25] | ||||
SECDS | x | [39] |
Legend: 6MWT = 6-Minute Walking Test; CDS = Cardiac Depression Scale; DASI = Duke Activity Status Index; DASS = Depression Anxiety Stress Scale; DBP = Diastolic Blood Pressure; HADS = Hospital Anxiety and Depression Scale; HDL = High-density lipoprotein; IPAQ = International Physical Activity Questionnaire; LDL = low-density lipoprotein; LVEF = Left Ventricular Ejection Fraction; METS = Metabolic Equivalent of Task; MPSS = Multidimensional Perceived Social Support Scale; PAEE = Physical Activity Energy Expenditure; per-Based = Performance-Based; PHQ = Patient Health Questionnaire; pr-Based = Patient-Reported Based; PSSS = Perceived Social Support Scale; RER = Respiratory Exchange Ratio, SBP = Systolic Blood pressure; SECDS = Social-Emotional and Character Development Scale; SF-12 = Short-form Health Survey 12; SF-36 = Short-form Health Survey 36; VO2 = max Oxygen Consumption; VT = ventilator threshold; WHOQOL = World Health Organization Quality of Life.